Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions
MedComm – Future Medicine · 2024-12 · 3 (4)
DOI: 10.1002/mef2.70004 ↗At a glance
Journal article in MedComm – Future Medicine, published online on 2024-12-04. Written by Laurence Si Chong Lok and 9 co-authors. Cited 13 times so far (Crossref); 204 references. The full text is freely available (open access, CC BY 4.0). Funded by: Macau University of Science and Technology.
Abstract (original language)
Long coronavirus disease (COVID) is characterized by persistent symptoms following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and has emerged as a significant health concern. As SARS‐CoV‐2 evolved from the wild‐type strain to the Alpha, Beta, Delta, and Omicron variants, there may be a variant‐specific influence on long COVID akin to the acute disease. This review aims to summarize our current knowledge of variant‐specific influences in long COVID incidence, symptom profile as well as mechanisms of pathogenesis. We highlight that long COVID incidence may be lower with the Omicron variants. The symptom profile of long COVID may also show some dependence on the different variants, with a reduction in cardiopulmonary symptoms with more recent SARS‐CoV‐2 variants. This heterogeneity of long COVID may also be related to the variant‐specific differences in affecting the immune system, viral persistence, and autoimmunity. However, emerging data also suggest that vaccinations may play a big role in shaping the presentation of long COVID. We also highlight ongoing work on long COVID incidence and symptom profiles in populations infected only by the Omicron variants. This will be beneficial toward more useful disease definitions and the development of effective diagnostic and therapeutic strategies.
Funding
- Macau University of Science and Technology
Cite
APA
Lok, L. S. C., Sarkar, S., Lam, C. C. I., Law, C. F., Chau, S. T., Leung, C. Y. T., Cheang, W. H., Li, T., Monteiro, O., & Baptista‐Hon, D. T. (2024). Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions. MedComm – Future Medicine, 3(4). https://doi.org/10.1002/mef2.70004
Vancouver
Lok LSC, Sarkar S, Lam CCI, Law CF, Chau ST, Leung CYT, et al. Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions. MedComm – Future Medicine. 2024;3(4). doi:10.1002/mef2.70004
BibTeX
@article{Lok2024,
author = {Lok, Laurence Si Chong and Sarkar, Shuvam and Lam, Calista Chi In and Law, Chak Fun and Chau, Sin Teng and Leung, Chun Yip Thomas and Cheang, Wai Hin and Li, Ting and Monteiro, Olivia and Baptista‐Hon, Daniel Tomas},
title = {Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions},
journal = {MedComm – Future Medicine},
year = {2024},
volume = {3},
number = {4},
doi = {10.1002/mef2.70004}
}
EUVIMED